관상동맥용 약물 코팅 풍선 카테터 시장 규모, 점유율, 동향 분석 보고서 : 적응증별, 약제 종류별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Coronary Drug-Coated Balloon Catheter Market Summary

The global coronary drug-coated balloon catheter market size was valued at USD 342.4 million in 2025 and is projected to grow from USD 374.9 million in 2026 to USD 727.2 million by 2033, at a CAGR of 9.9% from 2026 to 2033. North America dominated the market, accounting for a share of 44.1% in 2025. Increasing Percutaneous Coronary Intervention (PCI) volumes globally are driving the demand for coronary drug-coated balloon catheters, particularly for treating in-stent restenosis and complex coronary lesions.

In addition, comprehensive reimbursement coverage for coronary interventions in countries such as the U.S., Germany, and Japan is improving patient access and accelerating the adoption of drug-coated balloon technologies.

Market Dynamic

The rising prevalence of coronary artery disease (CAD), increasing volumes of PCI procedures, and growing adoption of minimally invasive coronary revascularization techniques are driving the growth of the coronary drug-coated balloon catheter market. Increasing incidences of in-stent restenosis (ISR), small vessel disease, and complex coronary lesions are accelerating the demand for an effective alternative to repeat stenting. Continuous advancements in drug-coating technologies, particularly the development of next-generation sirolimus-coated balloons, along with expanding clinical evidence and favorable regulatory approvals, are further supporting market adoption.

However, stringent regulatory approval requirements, extensive clinical trial obligations, and the high cost of advanced interventional procedures continue to restrain market growth. Expanding commercialization of innovative technologies, increasing physician preference for "leave nothing behind" treatment strategies, and growing adoption across emerging healthcare markets are expected to create significant growth opportunities during the forecast period.

Global Coronary Drug-Coated Balloon Catheter Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels, and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global coronary drug-coated balloon catheter market report on the basis of indication, drug type, end use, and region:

• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• In-Stent Restenosis (ISR)
• De-novo coronary lesions
• Complex / Adjunct Coronary Lesions
• Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
• Paclitaxel
• Sirolimus
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Cardiac/Vascular Centers
• Ambulatory Surgical Centers (ASCs)
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • Australia
  • India
• South Korea
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
• Latin America
  • Brazil
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Indication
  • 1.1.2. Drug Type
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Indication outlook
  • 2.2.2. Drug type outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Coronary Drug-Coated Balloon Catheters Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Coronary Drug-Coated Balloon Catheters Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Legal landscape
    • 3.3.2.6. Environmental landscape
• 3.4. Country-Level Market Driver Mapping (Coronary DCB)
  • 3.4.1. Regulatory Landscape Influencing the Coronary Drug-Coated Balloon Market Dynamics
  • 3.4.2. Clinical Trial Presence in Major Countries
  • 3.4.3. Global Distribution Footprint
  • 3.4.4. Pricing Competitiveness
• 3.5. Innovation & Product Development Analysis
  • 3.5.1. New Product Launches
  • 3.5.2. Product Pipeline
  • 3.5.3. Emerging Coating Technologies
• 3.6. Market Entry Attractiveness Assessment

Chapter 4. Coronary Drug-Coated Balloon Catheters Market: Indication Estimates & Trend Analysis

• 4.1. Definition and Scope
• 4.2. Indication Market Share, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Coronary Drug-Coated Balloon Catheters Market by Indication Area Outlook
• 4.5. In-Stent Restenosis (ISR)
  • 4.5.1. In-stent restenosis (ISR) market estimates and forecast, 2021 to 2033 (USD Million)
• 4.6. De-novo Coronary Lesions
  • 4.6.1. De-novo coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
• 4.7. Complex / Adjunct Coronary Lesions
  • 4.7.1. Complex / adjunct coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Coronary Drug-Coated Balloon Catheters Market: Technology Integration Estimates & Trend Analysis

• 5.1. Definition and Scope
• 5.2. Drug Type Market Share, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Coronary Drug-Coated Balloon Catheters Market by Drug Type Outlook
• 5.5. Paclitaxel
  • 5.5.1. Paclitaxel market estimates and forecast, 2021 to 2033 (USD Million)
• 5.6. Sirolimus
  • 5.6.1. Sirolimus market estimates and forecast, 2021 to 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Coronary Drug-Coated Balloon Catheters Market: End Use Estimates & Trend Analysis

• 6.1. Definition and Scope
• 6.2. End Use Market Share, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. Coronary Drug-Coated Balloon Catheters Market by End Use Outlook
• 6.5. E- Hospitals
  • 6.5.1. Hospitals market estimates and forecast, 2021 to 2033 (USD Million)
• 6.6. Specialty Cardiac/Vascular Centers
  • 6.6.1. Specialty cardiac/vascular centers market estimates and forecast, 2021 to 2033 (USD Million)
• 6.7. Ambulatory Surgical Centers (ASCs)
  • 6.7.1. Ambulatory surgical centers (ASCs) market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 7. Coronary Drug-Coated Balloon Catheters Market: Regional Estimates & Trend Analysis, By Indication, By Drug Type, By End Use

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.1.5. U.S. market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2.5. Canada market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3.5. Mexico market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.1.5. UK market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2.5. Germany market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3.5. France market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4.5. Italy market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5.5. Spain market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6.5. Norway market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7.5. Sweden market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8.5. Denmark market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.1.5. Japan market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2.5. China market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3.5. India market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4.5. Australia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5.5. South Korea market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6.5. Thailand market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.7. Indonesia
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Indonesia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7.5. Indonesia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.8. Malaysia
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8.5. Malaysia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6.9. Vietnam
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Regulatory framework
    • 7.6.9.3. Competitive scenario
    • 7.6.9.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.9.5. Vietnam market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.1.5. Brazil market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2.5. Argentina market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.7.3. Colombia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3.5. Colombia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.7.4. Chile
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4.5. Chile market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.1.5. South Africa market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2.5. Saudi Arabia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3.5. UAE market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4.5. Kuwait market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key Company Market Share Analysis, 2025 (%)
• 8.4. List of Companies
  • 8.4.1. Boston Scientific
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Lepu Medical
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Medtronic
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. B. Braun SE
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Concept Medical
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Teleflex Incorporated (BIOTRONIK)
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. MicroPort Scientific Corporation
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. iVascular S.L.U.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives